Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Lancet

- PMLiVE

Novartis reports primary endpoint reached in phase 3 malaria trial

The treatment demonstrated non-inferiority to current standard of care

- PMLiVE

UK researchers uncover first new asthma and COPD attack treatment in 50 years

The phase 2 study showed that benralizumab could be re-purposed for use in emergency settings

- PMLiVE

UK study reveals previously unknown genetic causes of colorectal cancer

The third most commonly diagnosed cancer globally is responsible for more than 44,000 new cases in the UK every year

- PMLiVE

Study reveals GSK’s new recombinant shingles vaccine could reduce dementia risk

Shingrix reduced dementia diagnoses by 17% compared to Merck & Co’s Zostavax after six years

- PMLiVE

Novo Nordisk’s Ozempic associated with cognitive benefits in diabetes patients

Researchers from the University of Oxford analysed records from more than 100 million patients in the US

- PMLiVE

Researchers’ new vaccine technology shows efficacy against broad range of coronaviruses

The vaccine provided protection against coronaviruses that have not yet emerged

- PMLiVE

New immune cell discovery could lead to personalised breast cancer treatments

The study revealed the key features of immune cells in helping the body’s immune system fight cancer

- PMLiVE

UK scientists reveal promising new treatment strategy for acute myeloid leukaemia

The aggressive form of blood cancer is responsible for more than 3,000 new cases in the UK every year

- PMLiVE

Scientists to develop vaccine to prevent lung cancer following £1.7m grant

Lung cancer is responsible for over 48,000 cases in the UK every year

- PMLiVE

New blood test could identify individuals at highest risk of developing heart failure

Measuring NPY alongside BNP could help healthcare professionals improve diagnosis for heart patients

dengue fever mosquito

Positive efficacy results for R21/Matrix-M malaria vaccine published in The Lancet

R21 was added to the World Health Organization's list of prequalified vaccines in December

- PMLiVE

Study finds vaccination against COVID-19 reduces long COVID symptoms

The results could help inform public health strategies and vaccination campaigns

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links